Leslie Suen writes about new research suggesting loosened methadone regulations have not led to more overdoses or drug sales as many have long feared.
Federal Policy
Posted inHealth Law
The FDA Super Bowl
We break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
Posted inMental Health
Answering the Call, Part 1: America’s New Mental Health Crisis Line
A new nationwide crisis line launches in July 2022. Will it be ready to meet America’s mental health needs?
Posted inHealth Law
Harm Reduction’s Road From Fringe to Federal Drug Policy
How a once taboo strategy to keep drug users safe has become more mainstream and what that could mean for our overdose crisis.
Posted inHealth Equity
How Immigration Enforcement Can Affect Newborns’ Health
Sebastian Tello-Trillo shares research on the impact of immigration enforcement fears on babies born to undocumented parents.
Posted inHealth Law
Can Democrats Reconcile Their Health Policy Differences?
Democratic lawmakers face tough health care compromises as they struggle to secure votes for their blockbuster spending bill.
Posted inCost of Care
What Happens When Price Transparency Meets Childbirth?
Jamie Daw looks at new research showing the uptake of a hospital price transparency tool for childbirth and its associations with cost of care.
Posted inInsurance
Why Millions Could Lose Medicaid Next Year
A congressional ban on removing anyone from Medicaid is likely to expire early next year.
Posted inHealth Equity
Catching America’s Top Cancer Killer
Doctors are pushing millions more Americans to get screened for lung cancer, but the test comes with tricky risks and tough barriers.
Posted inInsurance
3 Employers, 2 Wonks and 1 Health Insurance Mess (LIVE!)
In this live episode, policy experts and employers debate the best way to improve employer-based health insurance.